Publications by authors named "Scott B Saxman"

Claim this Profile
C
Commentary on Hey and Kimmelman.
Scott Brian Saxman

Clin Trials· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethical considerations for outcome-adaptive trial designs: a clinical researcher's perspective.
Scott Brian Saxman

Bioethics· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck.
Jay S Cooper, Qiang Zhang, Thomas F Pajak, Arlene A Forastiere, John Jacobs, Scott B Saxman

Int J Radiat Oncol Biol Phys· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment rationale and study design for a randomized trial of pemetrexed/carboplatin followed by maintenance pemetrexed versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevacizumab in patients with advanced non-small-cell lung cancer of nonsquamous histology.
Ralph G Zinner, Scott B Saxman, Guangbin Peng, Matthew J Monberg, Waldo I Ortuzar

Clin Lung Cancer· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.
Jay S Cooper, Thomas F Pajak, Arlene A Forastiere, John Jacobs, Bruce H Campbell, Scott B Saxman

N Engl J Med· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis